3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
6
Diffuse Intrinsic Pontine Glioma
3
Recurrence
2
Glioma
2
Brain Neoplasms
2
Central Nervous System Neoplasms
1
Brain Stem Neoplasms
1
Astrocytoma
1
Interventions
temsirolimus
1
rofecoxib
1
rindopepimut
1
ovex
1
imetelstat
1
entinostat
1
cixutumumab
1
azurin (50-77)
1
Re-Irradiation
1
Quality of Life
1
Piperazine
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Mebendazole
1
Irinotecan
1
Immunotherapy
1
GRN163L peptide
1
Everolimus
1
Drug Therapy
1
Dasatinib
1
Cisplatin
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Stem Neoplasms
×
Re-Irradiation
×
CNS
×
Clear all
NCT06093165
2023-10-23
REMIT
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
59 enrolled